Business Description
Legend Biotech is a New Jersey-based company focused on developing advanced cell-based treatments for cancer patients across the United States, China, and Europe. Its most prominent product, cilta-cel, is an approved therapy for multiple myeloma that works by reprogramming a patient's own immune cells to attack cancer. The company is also building a broader pipeline of treatments aimed at several other cancer types, while working alongside partners Janssen Biotech and Novartis to expand the reach and development of its therapies.
